Immune Netw.  2008 Jun;8(2):53-58. 10.4110/in.2008.8.2.53.

Expression of Gpnmb in NK Cell Development from Hematopoietic Stem Cells

Affiliations
  • 1Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejeon, Korea. ipchoi@kribb.re.kr

Abstract

BACKGROUND: Molecular mechanisms of natural killer (NK) cell development from hematopoietic stem cells (HSCs) have not been clearly elucidated, although the roles of some genes in NK cell development have been reported previously. Thus, searching for molecules and genes related NK cell developmental stage is important to understand the molecular events of NK cell development. METHODS: From our previous SAGE data-base, Gpnmb (Glycoprotein non-metastatic melanoma protein B) was selected for further analysis. We confirmed the level of mRNA and protein of Gpnmb through RT-PCR, quantitative PCR, and FACS analysis. Then we performed cell-based ELISA and FACS analysis, to know whether there are some molecules which can bind to Gpnmb. Using neutralizing antibody, we blocked the interaction between NK cells and OP9 cells, and checked IFN-gamma production by ELISA kit. RESULTS: Gpnmb expression was elevated during in vitro developmental stage and bound to OP9 cells, but not to NK precursor cells. In addition, we confirmed that the levels of Gpnmb were increased at NK precursor stage in vivo. We confirmed syndecan4 as a candidate of Gpnmb's binding molecule. When the interaction between NK cells and OP9 cells were inhibited in vitro, IFN-gamma production from NK cells were reduced. CONCLUSION: Based on these observations, it is concluded that Gpnmb has a potential role in NK cell development from HSCs.

Keyword

NK cell differentiation; gpnmb; natural killer cell

MeSH Terms

Antibodies, Neutralizing
Enzyme-Linked Immunosorbent Assay
Hematopoietic Stem Cells
Killer Cells, Natural
Melanoma
Polymerase Chain Reaction
RNA, Messenger
Syndecan-4
Antibodies, Neutralizing
RNA, Messenger
Syndecan-4
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr